| PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 3,182,000 | 3,317,000 | 3,125,000 | 2,962,000 | | Cost of Revenue | (1,531,000) | 1,902,000 | 3,155,000 | 2,556,000 | | | Gross Profit | 4,713,000 | 1,415,000 | (30,000) | 406,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,494,000 | 1,210,000 | (39,000) | 346,000 | | Non Recurring | 77,000 | 20,000 | 44,000 | 4,000 | | Others | 141,000 | 124,000 | 118,000 | 111,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,000 | 61,000 | (153,000) | (55,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 12,000 | 4,000 | 13,000 | 12,000 | | Earnings Before Interest And Taxes | 13,000 | 65,000 | (140,000) | (43,000) | | Interest Expense | 85,000 | 83,000 | 73,000 | 93,000 | | Income Before Tax | (72,000) | (18,000) | (213,000) | (136,000) | | Income Tax Expense | (157,000) |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 85,000 | (18,000) | (213,000) | (136,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 85,000 | (18,000) | (213,000) | (136,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $85,000 | ($18,000) | ($213,000) | ($136,000) |
|
0.16% Nasdaq 0.00%
Income Statement
